Xinhua Lande Scitech Co., Limited
Xinhua Lande Scitech Co., Limited Fundamental Analysis
Xinhua Lande Scitech Co., Limited (8106.HK) shows weak financial fundamentals with a PE ratio of 101.69, profit margin of 0.60%, and ROE of 2.87%. The company generates $0.2B in annual revenue with strong year-over-year growth of 88.65%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 45.0/100 based on profitability, valuation, growth, and balance sheet metrics. The D grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze 8106.HK's fundamental strength across five key dimensions:
Efficiency Score
Weak8106.HK struggles to generate sufficient returns from assets.
Valuation Score
Moderate8106.HK shows balanced valuation metrics.
Growth Score
Excellent8106.HK delivers strong and consistent growth momentum.
Financial Health Score
Excellent8106.HK maintains a strong and stable balance sheet.
Profitability Score
Weak8106.HK struggles to sustain strong margins.
Key Financial Metrics
Is 8106.HK Expensive or Cheap?
P/E Ratio
8106.HK trades at 101.69 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, 8106.HK's PEG of 0.74 indicates potential undervaluation.
Price to Book
The market values Xinhua Lande Scitech Co., Limited at 2.92 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 31.61 times EBITDA. This signals the market has high growth expectations.
How Well Does 8106.HK Make Money?
Net Profit Margin
For every $100 in sales, Xinhua Lande Scitech Co., Limited keeps $0.60 as profit after all expenses.
Operating Margin
Core operations generate 2.36 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $2.87 in profit for every $100 of shareholder equity.
ROA
Xinhua Lande Scitech Co., Limited generates $1.04 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Xinhua Lande Scitech Co., Limited generates limited operating cash flow of $-22.74M, signaling weaker underlying cash strength.
Free Cash Flow
Xinhua Lande Scitech Co., Limited generates weak or negative free cash flow of $-22.75M, restricting financial flexibility.
FCF Per Share
Each share generates $-0.04 in free cash annually.
FCF Yield
8106.HK converts -15.96% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
101.69
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.74
vs 25 benchmark
P/B Ratio
Price to book value ratio
2.92
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.62
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.60
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.54
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.03
vs 25 benchmark
ROA
Return on assets percentage
0.01
vs 25 benchmark
ROCE
Return on capital employed
0.11
vs 25 benchmark
How 8106.HK Stacks Against Its Sector Peers
| Metric | 8106.HK Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 101.69 | 33.94 | Worse (Expensive) |
| ROE | 2.87% | 1002.00% | Weak |
| Net Margin | 0.60% | -48794.00% (disorted) | Weak |
| Debt/Equity | 0.60 | 0.44 | Weak (High Leverage) |
| Current Ratio | 1.54 | 5.74 | Neutral |
| ROA | 1.04% | -288341.00% (disorted) | Weak |
8106.HK outperforms its industry in 0 out of 6 key metrics, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Xinhua Lande Scitech Co., Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
-36.52%
Industry Style: Growth, Innovation, High Beta
DecliningEPS CAGR
-241.01%
Industry Style: Growth, Innovation, High Beta
DecliningFCF CAGR
-44.96%
Industry Style: Growth, Innovation, High Beta
Declining